{"id":616450,"title":"Notice: Guidance on the Clinical Assessment of Abuse Liability for Drugs with Central Nervous System Activity  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T20:40:33.034000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/clinical-assessment-abuse-liability-drugs-central-nervous-system.html","snippet":"Notice: Guidance on the Clinical Assessment of Abuse Liability for Drugs with Central Nervous System Activity July 4, 2019 Our reference number: 19-111910-93 Health Canada continues to support regulatory alignment with other respected regulatory authorities, where possible. By…","rawSnapshotUrl":"/api/snapshots/raw/616450","browseUrl":"https://replay.healtharchive.ca/job-6/20260302204033/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/clinical-assessment-abuse-liability-drugs-central-nervous-system.html#ha_snapshot=616450","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}